Dow Down 0.17% Nasdaq Down 0.28%

Galena Biopharma, Inc. (GALE)

-NasdaqCM
2.06 Down 0.05(2.37%) Sep 30, 4:00PM EDT
|After Hours : 2.06 Up 0.00 (0.22%) Sep 30, 4:37PM EDT
Prev Close:2.11
Open:2.10
Bid:1.78 x 100
Ask:2.41 x 100
1y Target Est:5.91
Beta:1.08
Earnings Date:Nov 4 - Nov 10 (Est.)
Day's Range:2.04 - 2.13
52wk Range:1.66 - 7.77
Volume:1,933,473
Avg Vol (3m):2,055,730
Market Cap:243.50M
P/E (ttm):N/A
EPS (ttm):-0.75
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for GALE

Comparison

Symbol% ChgMkt Cap
GALEDown 2.37%243.50M
CELGDown 0.90%75.78B
VSTMDown 0.93%220.17M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):35.68
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.43
Quarterly EPS Est (Sep-14) :-0.11
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing and commercializing oncology treatments that address major unmet medical needs to advance cancer care. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback